Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Clinical trial NCT02132884 · TERMINATED

Trial details

NCT number: NCT02132884
Sponsor: Fox Chase Cancer Center
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Malignant Pericardial Effusion Malignant Pleural Effusion Recurrent Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer

Start date: 2015-03-01
Primary completion: 2016-08-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.